Identification of neurotoxic cytokines by profiling Alzheimer's disease tissues and neuron culture viability screening

• Main Authors: Wood, Levi B. (Author), Winslow, Ashley R. (Author), Proctor, Elizabeth A. (Contributor), McGuone, Declan (Author), Mordes, Daniel A. (Author), Frosch, Matthew P. (Author), Hyman, Bradley T. (Author), Lauffenburger, Douglas A. (Contributor), Haigis, Kevin M. (Author)
• Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor)
• Format: Article
• Language: English
• Published: Nature Publishing Group, 2016-01-19T20:50:28Z.
• Subjects: Article
• Online Access: Get fulltext

Alzheimer's disease (AD) therapeutics based on the amyloid hypothesis have shown minimal efficacy in patients, suggesting that the activity of amyloid beta (Aβ) represents only one aspect of AD pathogenesis. Since neuroinflammation is thought to play an important role in AD, we hypothesized that cytokines may play a direct role in promoting neuronal death. Here, we profiled cytokine expression in a small cohort of human AD and control brain tissues. We identified AD-associated cytokines using partial least squares regression to correlate cytokine expression with quantified pathologic disease state and then used neuron cultures to test whether cytokines up-regulated in AD tissues could affect neuronal viability. This analysis identified cytokines that were associated with the pathological severity. Of the top correlates, only TNF-α reduced viability in neuron culture when applied alone. VEGF also reduced viability when applied together with Aβ, which was surprising because VEGF has been viewed as a neuro-protective protein. We found that this synthetic pro-death effect of VEGF in the context of Aβ was commensurate with VEGFR-dependent changes in multiple signaling pathways that govern cell fate. Our findings suggest that profiling of tissues combined with a culture-based screening approach can successfully identify new mechanisms driving neuronal death.
United States. Army Research Office (Institute for Collaborative Biotechnologies Grant W911NF-09-0001)